Logo of Robert Koch InstituteLogo of Robert Koch Institute
Publication Server of Robert Koch Instituteedoc
de|en
View Item 
  • edoc-Server Home
  • Artikel in Fachzeitschriften
  • Artikel in Fachzeitschriften
  • View Item
  • edoc-Server Home
  • Artikel in Fachzeitschriften
  • Artikel in Fachzeitschriften
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.
All of edoc-ServerCommunity & CollectionTitleAuthorSubjectThis CollectionTitleAuthorSubject
PublishLoginRegisterHelp
StatisticsView Usage Statistics
All of edoc-ServerCommunity & CollectionTitleAuthorSubjectThis CollectionTitleAuthorSubject
PublishLoginRegisterHelp
StatisticsView Usage Statistics
View Item 
  • edoc-Server Home
  • Artikel in Fachzeitschriften
  • Artikel in Fachzeitschriften
  • View Item
  • edoc-Server Home
  • Artikel in Fachzeitschriften
  • Artikel in Fachzeitschriften
  • View Item
2021-01-01Zeitschriftenartikel DOI: 10.25646/7905
Heteromultivalent topology-matched nanostructures as potent and broad-spectrum influenza A virus inhibitors
Nie, Chuanxiong
Stadtmüller, Marlena
Parshad, Badri
Wallert, Matthias
Ahmadi, Vahid
Kerkhoff, Yannic
Bhatia, Sumati
Block, Stephan
Cheng, Chong
Wolff, Thorsten
Haag, Rainer
Here, we report the topology-matched design of heteromultivalent nanostructures as potent and broad-spectrum virus entry inhibitors based on the host cell membrane. Initially, we investigate the virus binding dynamics to validate the better binding performance of the heteromultivalent moieties as compared to homomultivalent ones. The heteromultivalent binding moieties are transferred to nanostructures with a bowl-like shape matching the viral spherical surface. Unlike the conventional homomultivalent inhibitors, the heteromultivalent ones exhibit a half maximal inhibitory concentration of 32.4 ± 13.7 μg/ml due to the synergistic multivalent effects and the topology-matched shape. At a dose without causing cellular toxicity, >99.99% reduction of virus propagation has been achieved. Since multiple binding sites have also been identified on the S protein of SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2), we envision that the use of heteromultivalent nanostructures may also be applied to develop a potent inhibitor to prevent coronavirus infection.
Files in this item
Thumbnail
eabd3803.full.pdf — Adobe PDF — 2.850 Mb
MD5: fcad20b1f07933f84043766600b47175
Cite
BibTeX
EndNote
RIS
(CC BY-NC 3.0 DE) Namensnennung - Nicht kommerziell 3.0 Deutschland(CC BY-NC 3.0 DE) Namensnennung - Nicht kommerziell 3.0 Deutschland(CC BY-NC 3.0 DE) Namensnennung - Nicht kommerziell 3.0 Deutschland
Details
Terms of Use Imprint Policy Data Privacy Statement Contact

The Robert Koch Institute is a Federal Institute

within the portfolio of the Federal Ministry of Health

© Robert Koch Institute

All rights reserved unless explicitly granted.

 
DOI
10.25646/7905
Permanent URL
http://dx.doi.org/10.25646/7905
HTML
<a href="http://dx.doi.org/10.25646/7905">http://dx.doi.org/10.25646/7905</a>